vimarsana.com

Page 4 - ஐரோப்பிய உயரும் தொழில்நுட்பம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

2CRSi SA: Additional information about Blade

2CRSi SA: Additional information about Blade. DJ 2CRSi SA: Additional information about Blade. 2CRSi SA 2CRSi SA: Additional information about Blade. 11-March-2021 / 18:11 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. = Press release Additional information about Blade Strasbourg (France), 11 March 2021 - 2CRSi (ISIN: FR0013341781), a designer and manufacturer of high-performance, energy-efficient IT servers, provides additional information to its shareholders regarding the Blade company and the ongoing legal proceedings. Update on Blade SAS As announced on 3 March, Blade SAS, the specialist of cloud PC for video game players, has been placed in receivership

2CRSi SA: Information following the initiation of the receivership procedure of Blade SAS Revised revenue target for 2020/21: EUR162-175 million

(1) DJ 2CRSi SA: Information following the initiation of the receivership procedure of Blade SAS. Revised revenue target for 2020/21: EUR162-175 million. 2CRSi SA 2CRSi SA: Information following the initiation of the receivership procedure of Blade SAS. Revised revenue target for 2020/21: EUR162-175 million. 03-March-2021 / 20:10 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. = Press release Information following the initiation of the receivership procedure of Blade SAS Revised revenue target for 2020/21: EUR162-175 million Strasbourg (France), March 3, 2021 - 2CRSi (ISIN: FR0013341781), a designer and manufacturer of high-performance,

PHARMAGEST GROUP strengthens its network in Paris Regions by acquiring ADI

PRESS RELEASE PHARMAGEST GROUP STRENGTHENS ITS DISTRIBUTION NETWORK IN THE GREATER PARIS REGION BY ACQUIRING ITS HISTORIC DISTRIBUTOR, ADI Pharmagest Group becomes the sole shareholder of ADI (Applications et Développements Informatiques), in which it previously held 50% of the capital. This acquisition enables the Group to control its historic distributor in Ile-de-France for more than 30 years. Highlighting Pharmagest Group’s commitment to strengthen its distribution network in the greater Paris region. Pharmagest Group ( Euronext Paris – Compartment B - ISIN : FR 0012882389), the leading provider of IT solutions for the healthcare sector in Europe, today announces having acquired the 50% stake held by Marc ABITBOL, founder of ADI, the distribution partner of Pharmagest Group’s solutions in Ile-de-France for more than 30 years.

2CRSi SA: 2CRSi signs a significant first contract with one of the world s leading banking groups

(2) DJ 2CRSi SA: 2CRSi signs a significant first contract with one of the world s leading banking groups. 2CRSi SA 2CRSi SA: 2CRSi signs a significant first contract with one of the world s leading banking groups. 11-Feb-2021 / 18:20 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. = Press release 2CRSi signs a significant first contract with one of the world s leading banking groups Strasbourg (France), February 11, 2021 - 2CRSi (ISIN: FR0013341781), a designer and manufacturer of high-performance, energy-efficient IT servers, announces that it has been selected by a French world-leading banking group to provide a

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.